Nktr Stock close

Nektar to Announce Top-line Data from the 16-Week Induction Period in REZOLVE-AD Phase 2b Study of Rezpegaldesleukin, a Regulatory T-cell Proliferator, in Atopic Dermatitis on June 24, 2025
Tuesday, 24 June 2025 20:20   Yahoo Financearrow_outward

REZOLVE-AD Phase 2b Study of Rezpegaldesleukin Meets Primary and Key Secondary Endpoints in Patients with Moderate-to-Severe Atopic Dermatitis
Tuesday, 24 June 2025 20:20   Longview News-Journalarrow_outward

Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Tuesday, 24 June 2025 20:20   Benzingaarrow_outward

Nektar Therapeutics Announces Positive Phase 2b Trial Results - TipRanks
Tuesday, 24 June 2025 20:19   TipRanksarrow_outward

Nektar Therapeutics stock soars after atopic dermatitis drug hits key targets - Investing.com Canada
Tuesday, 24 June 2025 20:05   Investing.com Canadaarrow_outward

Nektar stock surges after eczema trial win (NKTR:NASDAQ) - Seeking Alpha
Tuesday, 24 June 2025 20:04   Seeking Alphaarrow_outward

Nektar (NKTR) Announces Promising Phase 2b Results for Atopic Dermatitis Treatment | NKTR Stock News - GuruFocus
Tuesday, 24 June 2025 20:01   GuruFocusarrow_outward

Nektar Therapeutics Stock Rallies Sharply After-Hours With Major Skin Drug Results Just Hours Away - MSN
Tuesday, 24 June 2025 16:36   MSNarrow_outward

Nektar Therapeutics stock soars on upcoming atopic dermatitis data - Investing.com
Tuesday, 24 June 2025 04:50   Investing.comarrow_outward

Nektar Readies Major Phase 2b Results for Novel Atopic Dermatitis Treatment - Key Data Tomorrow - Stock Titan
Tuesday, 24 June 2025 04:30   Stock Titanarrow_outward

Zacks Research Issues Optimistic Forecast for NKTR Earnings - Defense World
Monday, 23 June 2025 13:25   Defense Worldarrow_outward

Nektar Therapeutics (NASDAQ:NKTR) Shares Fly 29% But Investors Aren't Buying For Growth - simplywall.st
Wednesday, 11 June 2025 19:01   Simplywall.starrow_outward

Nektar Therapeutics Increases Authorized Shares To 390 Million - MarketScreener
Saturday, 07 June 2025 04:36   MarketScreenerarrow_outward

$NKTR stock is up 15% today. Here's what we see in our data. - Nasdaq
Monday, 12 May 2025 15:00   Nasdaqarrow_outward

Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - PR Newswire
Wednesday, 12 March 2025 15:00   PR Newswirearrow_outward

Nektar Therapeutics drives upward momentum in drug developers index - BioWorld MedTech
Thursday, 13 June 2024 15:00   BioWorld MedTecharrow_outward

Biotech's Lawsuit With Eli Lilly Might Catalyze Stock - streetwisereports.com
Wednesday, 27 March 2024 15:00   Streetwisereports.comarrow_outward

symbol__ Stock Quote Price and Forecast - CNN
Sunday, 10 March 2024 02:26   CNNarrow_outward

A Bold Fund Blindsided by a Biotech Blowup - Morningstar
Tuesday, 13 September 2022 15:00   Morningstararrow_outward

Nektar drug key to multi-billion dollar BMS deal fails pivotal test in melanoma - MedCity News
Monday, 14 March 2022 15:00   MedCity Newsarrow_outward

Nektar Therapeutics Stock Poised for Significant Move - Investopedia
Monday, 15 July 2019 15:00   Investopediaarrow_outward

Nektar’s long-acting IL-2 NKTR-214 has 'zero value,' claims analyst - Fierce Biotech
Monday, 01 October 2018 15:00   Fierce Biotecharrow_outward

100 Days of Volatility: Yes, It’s Been That Wild - Barron's
Thursday, 10 May 2018 15:00   Barron'sarrow_outward

The Not-So-Subtle Reason Behind Nektar Therapeutics' 10% Pop - The Motley Fool
Wednesday, 10 May 2017 15:00   The Motley Foolarrow_outward

Nektar Therapeutics (NKTR) - Zacks Investment Research
Wednesday, 23 September 2009 04:27   Zacks Investment Researcharrow_outward